2 most recent filings and news items mentioning CERS. Updated every 60 seconds.
Earnings|GuidanceJul 30, 2026Neutral
Cerus reported total revenue of $63.3 million for Q2 2026 and raised its full-year 2026 product revenue guidance range to $229 to $231 million, driven by strong performance of its INTERCEPT Fibrinogen Complex franchise.
View filing at SEC.gov →
LeadershipJul 10, 2026Neutral
Cer Corp amended William Greenman's agreement to transition him from CEO to Executive Chairman with base salary of $500,000. The update outlines a temporary role until May 2027, signaling a planned succession process.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.